Recurrent Thyroid Gland Carcinoma

DrugDrug NameDrug Description
DrugDrug NameTargetType
DrugDrug NamePhaseStatusCount
DB08875Cabozantinib1Active Not Recruiting1
DB08912Dabrafenib1Active Not Recruiting1
DB01259Lapatinib1Active Not Recruiting1
DB06176Romidepsin1Recruiting1
DB04849Cediranib1 / 2Active Not Recruiting1
DB00480Lenalidomide1 / 2Active Not Recruiting1
DB08916Afatinib2Recruiting1
DB08885Aflibercept2Completed1
DB08875Cabozantinib2Active Not Recruiting1
DB08865Crizotinib2Recruiting1
DB08912Dabrafenib2Recruiting1
DB01254Dasatinib2Recruiting1
DB11795GSK-26367712Recruiting1
DB09078Lenvatinib2Recruiting1
DB09035Nivolumab2Recruiting1
DB09330Osimertinib2Recruiting1
DB09073Palbociclib2Recruiting1
DB06589Pazopanib2Active Not Recruiting1
DB09037Pembrolizumab2Recruiting1
DB06366Pertuzumab2Recruiting1
DB11689Selumetinib2Completed1
DB11689Selumetinib2Recruiting1
DB00398Sorafenib2Active Not Recruiting1
DB01268Sunitinib2Active Not Recruiting1
DB01268Sunitinib2Recruiting1
DB08911Trametinib2Recruiting2
DB00072Trastuzumab2Recruiting1
DB05773Trastuzumab emtansine2Recruiting1
DB08828Vismodegib2Recruiting1